Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet transfusion for intracerebral hemorrhage in patients using antiplatelet agents
NL-OMON28517Phase 3Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2008
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet transfusion in intracerebral hemorrhage (ICH) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Poor functional outcome at 3 months. Planned start Feb 2008; status: not yet recruiting.
02
Drugs
platelet transfusion
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON28517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28517.